Loading
JPXHealthcareMedical - Healthcare Information Services
Latest quote
¥2,667
+¥3.00 · +0.11%
Kusurinomadoguchi, Inc., established in 2004 and headquartered in Tokyo, Japan, develops and implements a diverse array of technology solutions specifically designed for pharmacies and the wider medical care sector throughout the country. Its comprehensive platform includes patient-facing services such as the EPARK drug counter, an online portal for locating and booking appointments at pharmacies, and the EPARK medicine notebook, which enables digital management of family prescriptions and reservation for medication dispensations. The company also offers a dedicated site facilitating telephone medical consultations for over-the-counter medicines, alongside a system allowing patients to select their preferred pharmacy for services, and provides online medication guidance as well as hospital-supported online consultations. For pharmacy operations and management, Kusurinomadoguchi delivers Health Tech Navi, an electronic medication history system, and the Care Daisy system, which integrates various recording tools and ICT devices. It further provides procurement solutions for pharmaceuticals, including a marketplace for dispensing pharmacies to efficiently buy and sell surplus or slow-moving inventory, extending to the management and acquisition of otherwise stagnant stock. The firm also features a centralized management system to streamline outpatient reception, appointment scheduling, and online medical treatments. Additionally, it offers Pharmacy Support, a robust customer relationship management (CRM) system tailored for engaging repeat patients, alongside specialized operational systems for dispensing pharmacies and a matching service connecting nursing care facilities with appropriate pharmacies.
Latest quote
¥2,667
+¥3.00 · +0.11%
Regular session · JST · Market data may be delayed.
Kusurinomadoguchi, Inc., established in 2004 and headquartered in Tokyo, Japan, develops and implements a diverse array of technology solutions specifically designed for pharmacies and the wider medical care sector throughout the country. Its comprehensive platform includes patient-facing services such as the EPARK drug counter, an online portal for locating and booking appointments at pharmacies, and the EPARK medicine notebook, which enables digital management of family prescriptions and reservation for medication dispensations. The company also offers a dedicated site facilitating telephone medical consultations for over-the-counter medicines, alongside a system allowing patients to select their preferred pharmacy for services, and provides online medication guidance as well as hospital-supported online consultations. For pharmacy operations and management, Kusurinomadoguchi delivers Health Tech Navi, an electronic medication history system, and the Care Daisy system, which integrates various recording tools and ICT devices. It further provides procurement solutions for pharmaceuticals, including a marketplace for dispensing pharmacies to efficiently buy and sell surplus or slow-moving inventory, extending to the management and acquisition of otherwise stagnant stock. The firm also features a centralized management system to streamline outpatient reception, appointment scheduling, and online medical treatments. Additionally, it offers Pharmacy Support, a robust customer relationship management (CRM) system tailored for engaging repeat patients, alongside specialized operational systems for dispensing pharmacies and a matching service connecting nursing care facilities with appropriate pharmacies.
Regular session · JST · Market data may be delayed.
Kusurinomadoguchi, Inc., established in 2004 and headquartered in Tokyo, Japan, develops and implements a diverse array of technology solutions specifically designed for pharmacies and the wider medical care sector throughout the country. Its comprehensive platform includes patient-facing services such as the EPARK drug counter, an online portal for locating and booking appointments at pharmacies, and the EPARK medicine notebook, which enables digital management of family prescriptions and reservation for medication dispensations. The company also offers a dedicated site facilitating telephone medical consultations for over-the-counter medicines, alongside a system allowing patients to select their preferred pharmacy for services, and provides online medication guidance as well as hospital-supported online consultations. For pharmacy operations and management, Kusurinomadoguchi delivers Health Tech Navi, an electronic medication history system, and the Care Daisy system, which integrates various recording tools and ICT devices. It further provides procurement solutions for pharmaceuticals, including a marketplace for dispensing pharmacies to efficiently buy and sell surplus or slow-moving inventory, extending to the management and acquisition of otherwise stagnant stock. The firm also features a centralized management system to streamline outpatient reception, appointment scheduling, and online medical treatments. Additionally, it offers Pharmacy Support, a robust customer relationship management (CRM) system tailored for engaging repeat patients, alongside specialized operational systems for dispensing pharmacies and a matching service connecting nursing care facilities with appropriate pharmacies.
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 12.33B JPY | 11.2B JPY | 8.72B JPY | 7.42B JPY | 6.49B JPY |
| Cost of goods sold | 5.36B JPY | 4.72B JPY | 3.79B JPY | 3.35B JPY | 3.12B JPY |
| Gross profit | 6.97B JPY | 6.48B JPY | 4.93B JPY | 4.07B JPY | 3.37B JPY |
| Selling, general, and administrative | 4.29B JPY | 4.52B JPY | 3.56B JPY | 3.02B JPY | 2.66B JPY |
| Operating expenses | 4.29B JPY | 4.52B JPY | 3.56B JPY | 3.02B JPY | 2.66B JPY |
| Interest income | 6.3M JPY | 5.12M JPY | — | — | — |
| Interest expense | 13.43M JPY | 5.9M JPY | 8.39M JPY | 9.68M JPY | 32.82M JPY |
| Depreciation and amortization | 1.5B JPY | 1.31B JPY | 1.03B JPY | 833.4M JPY | 676.44M JPY |
| Operating income | 2.68B JPY | 1.96B JPY | 1.37B JPY | 1.05B JPY | 715.03M JPY |
| Net income | 2.95B JPY | 2.03B JPY | 870.92M JPY | 391.45M JPY | 515.61M JPY |
Company facts updated Sep 7, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Mar 30, 2027 | ¥40.00Annual | Mar 31, 2027 | Mar 30, 2027 |
Dividend | Mar 30, 2026 | ¥38.00Annual | Mar 31, 2026 | Jun 12, 2026 |
Dividend | Mar 28, 2025 | ¥27.00Annual | Mar 31, 2025 | Jun 10, 2025 |
Ex-dividend Mar 30, 2027
¥40.00
Annual
Record Mar 31, 2027 · Payment Mar 30, 2027
Ex-dividend Mar 30, 2026
¥38.00
Annual
Record Mar 31, 2026 · Payment Jun 12, 2026
Ex-dividend Mar 28, 2025
¥27.00
Annual
Record Mar 31, 2025 · Payment Jun 10, 2025
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
